Results 161 to 170 of about 14,325 (202)

Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease. [PDF]

Eur Heart J
Kobayashi M, Pitt B, Ferreira JP, Rossignol P, Girerd N, Zannad F.   +5 more
europepmc   +1 more source

Dose optimization and utilization trends of mineralocorticoid receptor antagonists in heart failure patients with reduced ejection fraction in Ethiopia. [PDF]

Am Heart J Plus
Hassen M, Worku BT, Solomon T, Demessie MB, Wendie TF, Muhammed OS, Gobezie MY.   +6 more
europepmc   +1 more source

Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma

, 2012
Paraag Gide, Sandeep Sonawane, A.S. Chitnis   +2 more
openalex   +1 more source

Eplerenone for chronic central serous chorioretinopathy–a randomized controlled prospective study [PDF]

, 2017
Roy Schwartz, Zohar Habot‐Wilner, Michael R. Martinez, Amir Nutman, Dafna Goldenberg, Shai Cohen, Shiri Shulman, Hanan Guzner‐Gur, Anat Loewenstein, Michaella Goldstein   +9 more
openalex   +1 more source

Cardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading [PDF]

, 2002
Diego V. Martinez, Ricardo Rocha, Mamiko Matsumura, Eveline Oestreicher, Margarita Ochoa-Maya, Weranuj Roubsanthisuk, Gordon H. Williams, Gail K. Adler   +7 more
openalex   +1 more source

Eplerenone as a treatment for resistant hypertension in pregnancy [PDF]

, 2019
Jessica Gehlert, Adam Morton
openalex   +1 more source

Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Zhang Y, Bao YC, Wang LX, Zhao HJ, Sun J, Sun L, Duan W, Du M, Wang LJ, An QY, Yang WZ.   +10 more
europepmc   +1 more source

To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure. [PDF]

Front Cardiovasc Med
He J, Chen G, Huo Y, Zhang C, Xue H, Wang J, Zhong Y, Xiao J, Shen H, Feng J.   +9 more
europepmc   +1 more source

The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatment. [PDF]

Heart Fail Rev
Taub PR, Greene SJ, Fudim M.
europepmc   +1 more source

55 Eplerenone benefit in patients with elevated baseline heart rate in the EPHESUS trial

, 2005
H J Dargie, Jeffrey J. Anderson, H. Solomon, Robin Mukherjee, B. Pitt   +4 more
openalex   +2 more sources